Menu
Back to Journals » Cancer Management and Research » Volume 11
Original Research
CDKN3 promotes tumor progression and confers cisplatin resistance via RAD51 in esophageal cancer
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 5,424 | Dovepress* | 4,499+ | 934 | 5,433 | |
| PubMed Central* | 925 | 198 | 1,123 | ||
| Totals | 5,424 | 1,132 | 6,556 | ||
| *Since 15 April 2019 | |||||
View citations on PubMed Central and Google Scholar